---
layout: post
title: "Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments That Are Improperly Registered in the Electronic Human Cell and Tissue Establishment Registration System Due to Lack of Annual Registration Update; Action Dates"
date: 2026-02-05 18:55:44 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-11570
original_published: 2023-06-01 00:00:00 +0000
significance: 8.00
---

# Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments That Are Improperly Registered in the Electronic Human Cell and Tissue Establishment Registration System Due to Lack of Annual Registration Update; Action Dates

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** June 01, 2023 00:00 UTC
**Document Number:** 2023-11570

## Summary

The Food and Drug Administration (FDA) is announcing its intention to begin inactivating the registration of establishments that manufacture human cells, tissues, or cellular or tissue-based products (HCT/Ps) that have not updated their registration during the annual update period, in accordance with FDA regulations, in the electronic human cell and tissue establishment registration system (eHCTERS). FDA regulations require establishments that manufacture certain HCT/Ps to update their establishment registration annually. These regulations also require establishments to amend their registration within 30 calendar days of certain changes.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/06/01/2023-11570/human-cells-tissues-and-cellular-and-tissue-based-product-establishments-that-are-improperly)
- API: https://www.federalregister.gov/api/v1/documents/2023-11570

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
